Anti-Aging & Performance Program
Premium longevity and rejuvenation program combining mesenchymal stem cells and exosomes. Cellular-level regeneration for optimal ageing, vitality, and peak performance.
14+
Years of Clinical Experience
4,850+
Patients Treated Worldwide
UK
UK Corporate Structure
190+
Peer-Reviewed Publications
Cellular Rejuvenation for Optimal Longevity
Our Anti-Aging & Performance Program is designed for individuals seeking to optimise their biological age, restore vitality, and maintain peak physical and cognitive performance. This premium program combines the regenerative power of Wharton's jelly MSCs with advanced exosome therapy — the cutting edge of longevity medicine.
Unlike surface-level aesthetics, our approach targets ageing at the cellular level: reducing senescent cells, restoring mitochondrial function, modulating chronic low-grade inflammation (inflammaging), and replenishing the body's regenerative capacity. Backed by Prof. Dr. Karaöz's 190+ publications and our UK corporate structure, this is science-backed longevity, not speculation.
Conditions Treated in This Program
Your Rejuvenation Journey
A premium, personalised pathway to optimal ageing and peak performance
Longevity Assessment
Comprehensive biological age and health optimisation profiling
- Full blood panel including inflammatory markers and hormones
- Telomere length assessment (biological age indicator)
- Oxidative stress and antioxidant capacity markers
- Body composition and metabolic rate analysis
- Cardiovascular risk profiling
- Lifestyle, nutrition, and sleep quality assessment
Personalised Protocol Design
Your care plan, tailored to your biological profile
- Review of assessment results by Prof. Dr. Karaöz's team
- MSC and exosome dosing calibration
- Targeted delivery method selection
- Complementary therapy recommendations
- Expected outcomes discussion
- Video consultation with medical coordinator
Regenerative Treatment Phase
Combined MSC and exosome therapy at Liv Hospital Ulus
- Wharton's jelly MSC intravenous infusion (150–200M cells)
- MSC-derived exosome infusion for enhanced cell signalling
- Targeted exosome delivery for specific concerns (skin, joints, hair)
- NAD+ infusion for mitochondrial support (optional)
- Platelet-rich plasma (PRP) for hair or skin rejuvenation
- Post-treatment wellness assessment
Optimisation & Recovery
Post-treatment optimisation for maximum benefit
- Personalised nutrition and longevity diet plan
- Exercise and movement prescription
- Sleep optimisation protocol
- Supplement stack recommendation (CoQ10, NMN, resveratrol)
- Stress management and HRV training
- Skincare and topical exosome protocol
Longevity Follow-Up
12-month tracking of biological age markers
- Video consultations at 1, 3, 6, and 12 months
- Repeat biomarker testing and comparison
- Biological age recalculation
- Protocol refinement based on results
- Annual maintenance care planning
- Access to longevity concierge support
Rejuvenation Protocol
Our anti-aging program combines the most advanced regenerative modalities in longevity medicine
MSC Systemic Rejuvenation
150–200 million Wharton's jelly MSCs administered intravenously. Young, highly potent cells that target senescent cell clearance, reduce inflammaging, and replenish the body's declining stem cell reserves.
Exosome Cell Signalling Therapy
Billions of MSC-derived exosomes — nano-sized vesicles carrying regenerative RNA, proteins, and growth factors — that enhance cell-to-cell communication and activate dormant repair pathways throughout the body.
Targeted Aesthetic Delivery
Exosome micro-needling or injection for specific aesthetic concerns: facial rejuvenation, hair follicle stimulation, scar remodelling, and skin texture improvement. Combines with PRP for synergistic results.
Mitochondrial & NAD+ Support
Optional NAD+ infusion to support mitochondrial function — the cellular powerhouses that decline with age. Combined with MSC therapy, this addresses one of the fundamental hallmarks of ageing.
Longevity Lifestyle Integration
Our program extends beyond treatment into a comprehensive longevity lifestyle framework
UK-Registered Corporate Structure
StemCell Longevita operates under a UK corporate structure, providing international patients with the governance standards and consumer protections they expect.
- UK-registered company with full corporate transparency
- Contracts governed by English law for international patient protection
- Dedicated UK-based patient coordination and aftercare team
Frequently Asked Questions
What is the difference between MSCs and exosomes for anti-aging?
MSCs are living cells that engraft, secrete growth factors, and directly interact with damaged tissue. Exosomes are nano-sized vesicles produced by MSCs that carry regenerative RNA and proteins. Our program combines both: MSCs for systemic regeneration and exosomes for enhanced cell signalling and targeted aesthetic applications.
At what age should I consider this program?
Most clients begin between ages 35–65, when biological ageing accelerates. However, there is no strict age requirement — we assess biological age, not chronological age. Athletes and high-performers may start earlier for recovery and longevity optimisation.
How often should the approach be repeated?
We recommend an annual maintenance treatment for sustained anti-aging benefits. Some clients opt for twice-yearly treatments in the first year for accelerated results. Your follow-up assessments will guide the optimal frequency.
What results can I expect and when?
Most patients report improved energy, better sleep, enhanced skin quality, and cognitive clarity within 4–8 weeks. Biomarker improvements (inflammatory markers, oxidative stress) typically show within 3 months. Hair growth and skin rejuvenation from targeted exosome treatments develop over 3–6 months.
Related clinical questions
Where this page sits in the wider picture.